This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Yeda Research and Develpment & Co. Ltd, Yeda Research and Development Co. Ltd. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2026
Title: Tamar Paz-Elizur: Innovator in Cancer Research
Introduction
Tamar Paz-Elizur is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of cancer research, particularly in the development of diagnostic methods and therapeutic strategies. With a total of 3 patents, his work focuses on improving patient outcomes in cancer treatment.
Latest Patents
Tamar's latest patents include a groundbreaking DNA repair blood test designed to predict the response of lung cancer patients to immunotherapy. This innovative method involves the use of kits for determining the risk of developing cancer, evaluating the effectiveness and dosage of cancer therapy, and correlating the activity of DNA repair enzymes with cancer presence. These advancements hold promise for enhancing personalized medicine in oncology.
Career Highlights
Throughout his career, Tamar has worked with esteemed organizations such as Yeda Research and Development Co. Ltd. His research has been pivotal in advancing our understanding of cancer biology and treatment efficacy. His dedication to innovation in this field has positioned him as a key figure in cancer research.
Collaborations
Tamar has collaborated with notable colleagues, including Zvi Livneh and Sara Blumenstein. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Tamar Paz-Elizur's contributions to cancer research through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches continue to pave the way for advancements in cancer diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile